J&J Secures Key Support for $6.5 Billion Talc Settlement

Over 75% of claimants approve J&J's proposal, moving the company closer to resolving extensive litigation over talc products.

The settlement aims to address claims that J&J's talc products caused cancer, including ovarian and other gynecological cancers.
J&J's strategy involves a 'Texas two-step' bankruptcy to consolidate and resolve all lawsuits through a single settlement.
The company has faced legal challenges in previous attempts, with courts rejecting earlier bankruptcy filings.
Despite the progress, J&J still faces significant legal hurdles and opposition from some plaintiffs' attorneys.
The proposed settlement would distribute $6.5 billion over 25 years to resolve current and future claims.